Alizé Pharma presents clinical results from the AZP-531 program

Four projects supported by our foundation
27 May 2015
Alizé Pharma III raises €1.8 m in its first financing round
16 March 2015
0

Alizé Pharma presents clinical results from the AZP-531 program

Published by Octalfa at
Categories
    • Date26 April 2015

    The results from two Phase I clinical trials will be presented at the American Diabetes Association.